English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background The gastric cancer (GC) is the most common gastrointestinal tumor and it is the second cause of death in Mexico. Recently new agents chemotherapeutic, combinations and multimodal treatments have been developed. Traditionally your outcomes assessment is for clinical answers, tumor size, toxicity, survival free of disease or global survival. However, recently attention has been called to the assessment of quality of life, which OMS defines as the state of complete well-being, not only physique but also emotional and social. The quality of life implies the global evaluation that a person makes of his life with basis in his personal (demographic, value, personality, emotions, interpersonal relationships) characteristics and in external factors, provoked for illnesses and the treatment, includes the spheres physical, psychological and social health seen as different areas that are influenced by experiences, beliefs, expectations and people's perceptions. Each one can be measured in two dimensions: an objective evaluation and the individual's subjective perception. This last one can explain that two people with similar state of health can have very different quality of life. The assessment of the Quality of life has had a wide development, through generic questionnaires designed for patient with cancer, the EORTC has developed a modulate for patient with gastric cancer that evaluates the quality of life with related to the disfagia, feeding restrictions, reflux, and abdominal pain, as well as specific symptoms of the chemotherapy or radiotherapy the questionnaire QLQ STO-22. The objective of this study was to adapt and validate of the instrument EORTC QLQ-STO22 in a Mexican population from Instituto Nacional de Cancerologia (INCan)

Adaptation of the questionnaire EORTC QLQ-STO22 to measure quality of life from Mexican patients with gastric carcinoma